Full coverageUS approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir
By Andrew Owen
Top News
Wasted miracle? Concerns as revolutionary HIV drug approved
FDA approves first HIV prevention drug: All about it
Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a year
Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc
By Kevin Dunleavy
All coverage
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
By Brock Marchant
Regulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection
By Apoorva Mandavilli
HIV Prevention Has a Fantastic New Treatment
By Richard Seifman
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
By Sai Gopal
Twice-yearly HIV shot could stop transmission — if people can get it
By Lauran Neergaard
Cost Will Be Massive Barrier in Access to Lenacapavir After Approval in the US: Gordon Crofoot, MD, PA
By Julia Bonavitacola
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert
By Logan Lutton and Peter Wehrwein
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
By Laura Santhanam
Successful clinical trials for two injection a year for HIV treatment, with no side effects
By Sudeshna Panda
Here’s what everyone should know about this new HIV prevention shot
By Teddy Amenabar and Richard Sima
Drug that can prevent HIV approved in US | WHO to release guidelines for the drug in July | Inshorts
HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda
By Jonathan Lambert
FDA approves new twice-yearly HIV shot. What to know
By Ken Alltucker
US FDA approves Gilead's twice-yearly injection for HIV prevention
By Deena Beasley and Julie Steenhuysen
FDA approves twice-a-year injection for HIV prevention
By Jacqueline Howard
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
By Annika Kim Constantino
FDA Approves “Breakthrough” HIV Drug
By Jackie Flynn Mogensen